Considerations When Evaluating Cost-Effectiveness Analyses of Novel Stroke Prevention Therapies

The study by Reddy et al. (1) adds to the growing body of work evaluating the cost effectiveness of stroke prevention therapies from a U.S. perspective. We applaud their use of decision analytical models to inform practitioners and payers. We highlight 3 important considerations for readers of this work.

Source: Journal of the American College of Cardiology - May 3, 2016 Category: Cardiology Source Type: research